Name
Plenary Session II
Date & Time
Thursday, September 5, 2024, 1:20 PM - 1:40 PM
Description

PLENARY SESSION II

Session Chair: Susan O'Brien

BCL2 Inhibition in CLL: From Undruggable Target to Standard of Care | John Seymour, MBBS, FRACP, PhD | Peter MacCallum Cancer Centre, Melbourne, Australia

John Seymour Susan O'Brien
Speakers
John Seymour, Peter MacCallum Cancer Center
Susan O'Brien, University of California, Irvine
Location Name
GENERAL ASSEMBLY HALL
Virtual Session Link
Go To Session